Aanvullende literatuurlijst
Overlap syndromen:
Pope JE. Musculoskeletal involvement in scleroderma. Rheum Dis Clin North Am. 2003
May;29(2):391-408.
Andonopoulos AP, Papathanasopoulos PG, Karatza C, Angelopoulos J, Papapetropoulos T. Sjogren's
syndrome in systemic lupus erythematosus. J Rheumatol. 1990; 17 (2) : 201-4.
Kauppi M, Pukkala E, Isomaki H.Elevated incidence of hematologic malignancies in patients with
Sjogren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes
Control 1997; 8 (2) :201-4.
Nossent JC, Swaak AJ.. Systemic lupus erythematosus VII: frequency and impact of secondary
Sjogren's syndrome. Lupus 1998;7(4):231-4.
Sutcliffe N, Stoll T, Pyke S, Isenberg DA. Functional disability and end organ damage in patients with
systemic lupus erythematosus (SLE), SLE and Sjogren's syndrome (SS), and primary SS.
J Rheumatol. 1998; 25 (1): 63-8.
MCTD
Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease--an
apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable
nuclear antigen (ENA). Am. J Med. 1972; 52 (2) : 148-59
Reichlin M. Problems in differentiating SLE and mixed connective-tissue disease. N Engl J Med 1976
18 ; 295 (21) : 1194-5.
Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connective tissue disease: a subsequent
evaluation of the original 25 patients. Medicine (Baltimore) 1980; 59 (4) : 239-48.
Sharp GC. Diagnostic criteria for classification of MCTD. In Kasukawa R, Sharp GC, eds. Mixed
Connective Tissue Disease and Antinuclear antibodies. Amsterdam: Elsevier, 1987; 23-32
Alarcon-Segovia D, Villareal M: Classification and diagnostic criteria for mixed connective tissue
disease. In Kasukawa R, Sharp GC, eds. Mixed Connective Tissue Disease and Antinuclear
antibodies. Amsterdam: Elsevier, 1987; 33-40
Kasukawa R, Tojo T, Miyawaki S. Preliminary classification criteria for mixed connective tissue
disease. In Kasukawa R, Sharp GC, eds. Mixed Connective Tissue Disease and Antinuclear
antibodies. Amsterdam: Elsevier, 1987; 41-7
Alarcon-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective
tissue disease. Study of 593 patients. J Rheumatol. 1989; 16 (3): 328-34.
De Clerck LS, Meijers KA, Cats A. Is MCTD a distinct entity? Comparison of clinical and laboratory
findings in MCTD, SLE, PSS, and RA patients. Clin Rheumatol. 1989; 8 (1):29-36.
van den Hoogen FH, Spronk PE, Boerbooms AM, Bootsma H, de Rooij DJ, Kallenberg CG, van de
Putte LB. Long-term follow-up of 46 patients with anti-(U1)snRNP antibodies. Br J Rheumatol. 1994;
33 (12) : 1117-20
Farhey Y, Hess EV. Mixed Connective Tissue Disease. Arthritis Care and Research 1997:10 (5);33342.
UCTD
Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ. Development of connective tissue disease in
patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive
value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis. 1988; 47 (8) : 634-41.
Ganczarczyk L, Urowitz MB, Gladman DD. "Latent lupus". J Rheumatol. 1989 ;16 (4) : 475-8.
Clegg DO, Williams HJ, Singer JZ, Steen VD, Schlegel S, Ziminski C, Alarcon GS, Luggen ME,
Polisson RP, Willkens RF, Yarboro C, McDuffie FC, Ward JR.Early undifferentiated connective
tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic
diseases. J Rheumatol. 1991;18: 1340-3
Calvo-Alen J, Alarcon GS, Burgard SL, Burst N, Bartolucci AA, Williams HJ. Systemic lupus
erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated
connective tissue disease: multivariate analyses and identification of risk factors. J Rheumatol. 1996 ;
23 (3) : 469-75.
Williams HJ, Alarcon GS, Neuner R, Steen VD, Bulpitt K, Clegg DO, Ziminski CM, Luggen ME,
Polisson RP, Willkens RF, Yarboro C, Morgan J, Egger MJ, Ward JR. Early undifferentiated
connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in
diagnoses in well established and undifferentiated connective tissue diseases. J Rheumatol. 1998 ; 25
(2) : 261-8.
Danieli MG, Fraticelli P, Salvi A, Gabrielli A, Danieli G. Undifferentiated connective tissue disease:
natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early
UCTD. Clin Rheumatol. 1998;17(3):195-201.
Williams HJ, Alarcon GS, Joks R, Steen VD, Bulpitt K, Clegg DO, Ziminski CM, Luggen ME, St
Clair EW, Willkens RF, Yarboro C, Morgan JG, Egger MJ, Ward JR. Early undifferentiated
connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and
changes in diagnoses in well established and undifferentiated CTD. J Rheumatol. 1999 ; 26 (4) : 81625.
Cavazzana I, Franceschini F, Belfiore N, Quinzanini M, Caporali R, Calzavara-Pinton P, Bettoni L,
Brucato A, Cattaneo R, Montecucco C. Undifferentiated connective tissue disease with antibodies to
Ro/SSa: clinical features and follow-up of 148 patients. Clin Exp Rheumatol. 2001; 19 (4) : 403-9.
Danieli MG, Fraticelli P, Franceschini F, Cattaneo R, Farsi A, Passaleva A, Pietrogrande M,
Invernizzi F, Vanoli M, Scorza R, Sabbadini MG, Gerli R, Corvetta A, Farina G, Salsano F, Priori R,
Valesini G, Danieli G. Five-year follow-up of 165 Italian patients with undifferentiated connective
tissue diseases. Clin Exp Rheumatol. 1999 ; 17 (5) : 585-91.
Swaak AJ, van de Brink H, Smeenk RJ, Manger K, Kalden JR, Tosi S, Marchesoni A, Domljan Z,
Rozman B, Logar D, Pokorny G, Kovacs L, Kovacs A, Vlachoyiannopoulos PG, Moutsopoulos HM,
Chwalinska-Sadowska H, Dratwianka B, Kiss E, Cikes N, Anic B, Schneider M, Fischer R,
Bombardieri S, Mosca M, Graninger W, Smolen JS; Study group on incomplete SLE and SLE with
disease duration longer than 10 years. Incomplete lupus erythematosus: results of a multicentre study
under the supervision of the EULAR Standing Committee on International Clinical Studies Including
Therapeutic Trials (ESCISIT). Rheumatology (Oxford). 2001; 40 (1 ): 89-94.
Mosca M, Neri R, Bencivelli W, Tavoni A, Bombardieri S. Undifferentiated connective tissue disease:
analysis of 83 patients with a minimum followup of 5 years. J Rheumatol. 2002 ;29 (11) : 2345-9.
Whiley FM. Raynaud’s phenomenon. New Engl J Med 2002; 347 (13):1001-8
Cutolo M, Grassi W, Cerinici M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis
Rheum. 2003 ; 48 (11) :3023-30